Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

NIDA Home > Publications > Director's Reports > May, 2010 Index    

Director's Report to the National Advisory Council on Drug Abuse - May, 2010



Extramural Policy and Review Activities

Receipt, Referral, and Review

NIDA received 1485 applications, including both primary and dual assignments, for which the Office of Extramural Affairs (OEA) managed the programmatic referral process during this Council cycle. Of these, NIDA received the primary assignment on 1053 applications.

OEA arranged and managed 18 grant review meetings in which 321 applications were evaluated. OEA's reviews included applications in chartered, standing review committees and Special Emphasis Panels (SEPs). In addition, OEA staff arranged and managed 7 contract proposal review meetings.

NIDA has one standing chartered committee, NIDA-K (Training Committee). Applications formerly assigned to NIDA E (Treatment Review Committee), NIDA-F (Health Services Review Committee), and NIDA-L (Medications Development Committee) are now reviewed in CSR.

OEA staff managed 17 Special Emphasis Panels to review grant applications for a variety of reasons:

  • Conflicts with the chartered committee
  • Center Grant Applications
  • Program Project Grant Applications (P01)
  • Behavioral Science Track Award for Rapid Transition (B/START)
  • Imaging Science Track Award for Research Transition (I/START)
  • Conference Grants (R13)
  • Cutting-Edge Basic Research Awards (CEBRA)
  • Diversity-promoting Institutions Drug Abuse Research Program (DIDARP-R24)
  • Loan Repayment Applications
  • Requests for Applications (RFAs)

OEA managed the following RFA reviews:

  • DA10-001/002 - Substance Use and Abuse among U.S. Military Personnel, Veterans and their Families (R01 & R21)
  • DA10-005 - Targeted Library Synthesis and Screening at Novel Targets for Potential Drug Addiction Treatments and Research Tools (R21/R33)
  • DA10-008 - International Research Collaborations on HIV/AIDS and Drug Use (R01)
  • DA10-009 - The National Drug Abuse Treatment Clinical Trials Network (U10)
  • DA10-010/011 - Exploring Epigenomic Processes and Non-Coding RNAs in HIV/AIDS (R01 & R21)

Completed contract-related review activity from the Contracts Review Branch since the last Council includes:

R&D and non-R&D Contract Reviews

  • NO1DA-10-2221 - Clinical Coordinating Support for NIDA Center for Clinical Trials Network (CCTN)

Phase II SBIR Contract Reviews

  • N44DA-10-5556 - Rapid Assessment for Drug Abuse and Risky Sex
  • N44DA-10- 5555 - Rapid Assessment Tools of Sexual and Drug Use Risk Behaviors
  • N44DA-10- 4411 - Web-Enabled Cognitive/Neuropsychological Evaluation System
  • N44DA-10-1138 - Development of Science Education Materials or Programs
  • N44DA-10-5544 - Virtual Reality Simulations to Train Caregivers/Providers
  • N44DA-10-5541 - Instrument Development

Certificates of Confidentiality

Between January 5, 2010 and April 2, 2010, OEA processed 75 Certificate of Confidentiality applications, including 12 amendments for either extension of expiration date or protocol change.

CTN-Related Review Activities

The CTN Protocol Review Board met on January 26, 2010 to review the study proposal CTN 0047, Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED).

The Protocol Review Board met on January 29, 2010 to review the study proposal CTN 0048, Cocaine Use Reduction with Buprenorphine (CURB).

The Data and Safety Monitoring Board met March 22, 2010 to discuss the final study report for CTN 0030, Prescription Opioid Addiction Treatment Study (POATS).

Staff Training and Development

The OEA Symposium Series, a forum for staff training and sharing of ideas and information, continued to provide open forums for discussions and presentations that included: Enhancing Peer Review: New Application Forms and Instructions; Demonstration of Secondary PO and Conflict Of Interest functionality in NEPS, by James Wilson (IRMB) and Meena Hiremath (OEA); and a presentation on the Freedom of Information Act, by Susan Cornell, NIH FOIA Officer.


Index

Research Findings

Program Activities

Extramural Policy and Review Activities

Congressional Affairs

International Activities

Meetings and Conferences

Media and Education Activities

Planned Meetings

Publications

Staff Highlights

Grantee Honors



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal